Figure S3 from Phase I Trial of Intravenous VCN-01 Oncolytic Adenovirus and Durvalumab in Patients with Head and Neck Metastatic Squamous Cell Carcinoma Refractory to Immunotherapy
Year: 2026
Type: other
Abstract: Quantification of Anti-Ad5 neutralizing antibodies (Nabs) in patient serum
Authors: Maria Jove, Irene Braña, Marc Oliva, Alberto Hernando-Calvo, Carlos Erasun, Ana Mato-Berciano, Maria Victoria Maliandi, Silvia Torres-Manjon, Luis A. Rojas, Sheila Connelly, Miriam Bazan-Peregrino, Rafael Moreno, Jaime Martínez de Villarreal, Francisco X. Real, Charles Le, Paolo Nuciforo, Ramon Alemany, Gabriel Capellà, Carmen Blasco, Manel Cascalló, Ricard Mesía
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W7204874164